| Date | TitleTitle | ||||
|---|---|---|---|---|---|
| 06/08/24 | 13:41:12 | 6 Aug 2024 | Holding(s) in Company | RNS | |
| 28/06/24 | 12:17:10 | 28 Jun 2024 | Result of AGM | RNS | |
| 06/06/24 | 16:20:00 | 6 Jun 2024 | Holding(s) in Company | RNS | |
| 05/06/24 | 14:01:55 | 5 Jun 2024 | Notice of AGM & Annual Report & Accounts | RNS | |
| 05/06/24 | 07:00:06 | 5 Jun 2024 | Final Results | RNS | |
| 03/06/24 | 10:09:51 | 3 Jun 2024 | Realisation-c£1.5m on sale of shares in Incanthera | RNS | |
| 03/05/24 | 07:00:10 | 3 May 2024 | Holding(s) in Company | RNS | |
| 24/04/24 | 07:12:28 | 24 Apr 2024 | IMMUPHARMA AT BIO-EQUITY 2024 12-14 May | RNS | |
| 19/04/24 | 07:00:08 | 19 Apr 2024 | Grant of Share Options | RNS | |
| 02/04/24 | 07:03:05 | 2 Apr 2024 | New intellectual property strategy initiated | RNS | |
| 25/03/24 | 07:25:30 | 25 Mar 2024 | Incanthera provides Comm'l Update/Revenue F'casts | RNS | |
| 19/03/24 | 07:00:11 | 19 Mar 2024 | Grant of Share Options | RNS | |
| 14/03/24 | 07:00:11 | 14 Mar 2024 | IMMUPHARMA AT BIO-EUROPE SPRING 2024 | RNS | |
| 06/03/24 | 07:00:09 | 6 Mar 2024 | Financial, Business and Portfolio Develop't Update | RNS | |
| 28/12/23 | 13:35:44 | 28 Dec 2023 | Holding(s) in Company | RNS | |
| 19/12/23 | 14:50:48 | 19 Dec 2023 | Holding(s) in Company | RNS | |
| 19/12/23 | 07:00:12 | 19 Dec 2023 | Simbec-Orion appointed as CRO | RNS | |
| 18/12/23 | 07:15:00 | 18 Dec 2023 | Incanthera - Comm'l Skincare Deal/£1M Fundraise | RNS | |
| 13/09/23 | 15:47:06 | 13 Sept 2023 | Holding(s) in Company | RNS | |
| 07/09/23 | 07:00:07 | 7 Sept 2023 | Result of Retail Offer and Director Shareholding | RNS | |
| 06/09/23 | 13:53:00 | 6 Sept 2023 | Holding(s) in Company | RNS | |
| 31/08/23 | 07:02:01 | 31 Aug 2023 | WRAP Retail Offer for up to £0.5m | RNS | |
| 31/08/23 | 07:01:01 | 31 Aug 2023 | Subscription to raise £1.35m; Sharing Agr, RPT | RNS | |
| 31/08/23 | 07:00:06 | 31 Aug 2023 | Interim results | RNS | |
| 21/08/23 | 07:00:03 | 21 Aug 2023 | Extension of warrants in Incanthera plc | RNS | |
| 11/08/23 | 12:04:47 | 11 Aug 2023 | Directorate Change | RNS | |
| 30/06/23 | 13:12:37 | 30 Jun 2023 | Result of AGM | RNS | |
| 19/06/23 | 07:00:04 | 19 Jun 2023 | Lupuzor Update | RNS | |
| 06/06/23 | 07:00:08 | 6 Jun 2023 | IMM RNS Posting of RA and Notice of AGM 30 June 23 | RNS | |
| 18/05/23 | 07:00:07 | 18 May 2023 | Positive Pre-IND meeting with FDA | RNS | |
| 11/05/23 | 07:00:04 | 11 May 2023 | Final Results | RNS | |
| 10/05/23 | 13:56:36 | 10 May 2023 | Holding(s) in Company | RNS | |
| 19/04/23 | 07:00:05 | 19 Apr 2023 | Lupozor Update - FDA confirms Type-C meeting date | RNS | |
| 12/04/23 | 07:00:03 | 12 Apr 2023 | CIDP P140 Clinical Program Update | RNS | |
| 27/03/23 | 07:00:04 | 27 Mar 2023 | Lupuzor™ Update | RNS | |
| 09/03/23 | 16:35:29 | 9 Mar 2023 | Price Monitoring Extension | RNS | |
| 06/03/23 | 07:00:03 | 6 Mar 2023 | Collaboration with Orano on ImmuPharma Peptide | RNS | |
| 06/02/23 | 07:00:03 | 6 Feb 2023 | Lupuzor™ Update | RNS | |
| 27/01/23 | 16:25:02 | 27 Jan 2023 | TR-1: Notification of major holdings | RNS | |
| 04/01/23 | 17:26:38 | 4 Jan 2023 | TR-1: Notification of major holdings | RNS | |
| 04/01/23 | 16:40:26 | 4 Jan 2023 | Second Price Monitoring Extn | RNS | |
| 04/01/23 | 16:35:05 | 4 Jan 2023 | Price Monitoring Extension | RNS | |
| 03/01/23 | 16:58:49 | 3 Jan 2023 | TR-1: Notification of major holdings | RNS | |
| 22/12/22 | 07:55:00 | 22 Dec 2022 | Grant of Options | RNS | |
| 22/12/22 | 07:00:05 | 22 Dec 2022 | End of Year Update | RNS | |
| 22/11/22 | 15:15:25 | 22 Nov 2022 | Holding(s) in Company | RNS | |
| 14/11/22 | 16:40:29 | 14 Nov 2022 | Second Price Monitoring Extn | RNS | |
| 14/11/22 | 16:35:23 | 14 Nov 2022 | Price Monitoring Extension | RNS | |
| 11/11/22 | 07:31:50 | 11 Nov 2022 | Lupuzor Update | RNS | |
| 11/10/22 | 16:40:27 | 11 Oct 2022 | Second Price Monitoring Extn | RNS |
| Date | TitleTitle | ||||
|---|---|---|---|---|---|
| 06/08/24 | 13:41:12 | 6 Aug 2024 | Holding(s) in Company | RNS | |
| 28/06/24 | 12:17:10 | 28 Jun 2024 | Result of AGM | RNS | |
| 06/06/24 | 16:20:00 | 6 Jun 2024 | Holding(s) in Company | RNS | |
| 05/06/24 | 14:01:55 | 5 Jun 2024 | Notice of AGM & Annual Report & Accounts | RNS | |
| 05/06/24 | 07:00:06 | 5 Jun 2024 | Final Results | RNS | |
| 03/06/24 | 10:09:51 | 3 Jun 2024 | Realisation-c£1.5m on sale of shares in Incanthera | RNS | |
| 03/05/24 | 07:00:10 | 3 May 2024 | Holding(s) in Company | RNS | |
| 24/04/24 | 07:12:28 | 24 Apr 2024 | IMMUPHARMA AT BIO-EQUITY 2024 12-14 May | RNS | |
| 19/04/24 | 07:00:08 | 19 Apr 2024 | Grant of Share Options | RNS | |
| 02/04/24 | 07:03:05 | 2 Apr 2024 | New intellectual property strategy initiated | RNS | |
| 25/03/24 | 07:25:30 | 25 Mar 2024 | Incanthera provides Comm'l Update/Revenue F'casts | RNS | |
| 19/03/24 | 07:00:11 | 19 Mar 2024 | Grant of Share Options | RNS | |
| 14/03/24 | 07:00:11 | 14 Mar 2024 | IMMUPHARMA AT BIO-EUROPE SPRING 2024 | RNS | |
| 06/03/24 | 07:00:09 | 6 Mar 2024 | Financial, Business and Portfolio Develop't Update | RNS | |
| 28/12/23 | 13:35:44 | 28 Dec 2023 | Holding(s) in Company | RNS | |
| 19/12/23 | 14:50:48 | 19 Dec 2023 | Holding(s) in Company | RNS | |
| 19/12/23 | 07:00:12 | 19 Dec 2023 | Simbec-Orion appointed as CRO | RNS | |
| 18/12/23 | 07:15:00 | 18 Dec 2023 | Incanthera - Comm'l Skincare Deal/£1M Fundraise | RNS | |
| 13/09/23 | 15:47:06 | 13 Sept 2023 | Holding(s) in Company | RNS | |
| 07/09/23 | 07:00:07 | 7 Sept 2023 | Result of Retail Offer and Director Shareholding | RNS | |
| 06/09/23 | 13:53:00 | 6 Sept 2023 | Holding(s) in Company | RNS | |
| 31/08/23 | 07:02:01 | 31 Aug 2023 | WRAP Retail Offer for up to £0.5m | RNS | |
| 31/08/23 | 07:01:01 | 31 Aug 2023 | Subscription to raise £1.35m; Sharing Agr, RPT | RNS | |
| 31/08/23 | 07:00:06 | 31 Aug 2023 | Interim results | RNS | |
| 21/08/23 | 07:00:03 | 21 Aug 2023 | Extension of warrants in Incanthera plc | RNS | |
| 11/08/23 | 12:04:47 | 11 Aug 2023 | Directorate Change | RNS | |
| 30/06/23 | 13:12:37 | 30 Jun 2023 | Result of AGM | RNS | |
| 19/06/23 | 07:00:04 | 19 Jun 2023 | Lupuzor Update | RNS | |
| 06/06/23 | 07:00:08 | 6 Jun 2023 | IMM RNS Posting of RA and Notice of AGM 30 June 23 | RNS | |
| 18/05/23 | 07:00:07 | 18 May 2023 | Positive Pre-IND meeting with FDA | RNS | |
| 11/05/23 | 07:00:04 | 11 May 2023 | Final Results | RNS | |
| 10/05/23 | 13:56:36 | 10 May 2023 | Holding(s) in Company | RNS | |
| 19/04/23 | 07:00:05 | 19 Apr 2023 | Lupozor Update - FDA confirms Type-C meeting date | RNS | |
| 12/04/23 | 07:00:03 | 12 Apr 2023 | CIDP P140 Clinical Program Update | RNS | |
| 27/03/23 | 07:00:04 | 27 Mar 2023 | Lupuzor™ Update | RNS | |
| 09/03/23 | 16:35:29 | 9 Mar 2023 | Price Monitoring Extension | RNS | |
| 06/03/23 | 07:00:03 | 6 Mar 2023 | Collaboration with Orano on ImmuPharma Peptide | RNS | |
| 06/02/23 | 07:00:03 | 6 Feb 2023 | Lupuzor™ Update | RNS | |
| 27/01/23 | 16:25:02 | 27 Jan 2023 | TR-1: Notification of major holdings | RNS | |
| 04/01/23 | 17:26:38 | 4 Jan 2023 | TR-1: Notification of major holdings | RNS | |
| 04/01/23 | 16:40:26 | 4 Jan 2023 | Second Price Monitoring Extn | RNS | |
| 04/01/23 | 16:35:05 | 4 Jan 2023 | Price Monitoring Extension | RNS | |
| 03/01/23 | 16:58:49 | 3 Jan 2023 | TR-1: Notification of major holdings | RNS | |
| 22/12/22 | 07:55:00 | 22 Dec 2022 | Grant of Options | RNS | |
| 22/12/22 | 07:00:05 | 22 Dec 2022 | End of Year Update | RNS | |
| 22/11/22 | 15:15:25 | 22 Nov 2022 | Holding(s) in Company | RNS | |
| 14/11/22 | 16:40:29 | 14 Nov 2022 | Second Price Monitoring Extn | RNS | |
| 14/11/22 | 16:35:23 | 14 Nov 2022 | Price Monitoring Extension | RNS | |
| 11/11/22 | 07:31:50 | 11 Nov 2022 | Lupuzor Update | RNS | |
| 11/10/22 | 16:40:27 | 11 Oct 2022 | Second Price Monitoring Extn | RNS |
